rs10735005

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_172364.5(CACNA2D4):​c.979A>G​(p.Ile327Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.896 in 1,612,314 control chromosomes in the GnomAD database, including 648,295 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Uncertain significance in ClinVar.

Frequency

Genomes: 𝑓 0.92 ( 64041 hom., cov: 30)
Exomes 𝑓: 0.89 ( 584254 hom. )

Consequence

CACNA2D4
NM_172364.5 missense

Scores

1
16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 3.20

Publications

39 publications found
Variant links:
Genes affected
CACNA2D4 (HGNC:20202): (calcium voltage-gated channel auxiliary subunit alpha2delta 4) This gene encodes a member of the alpha-2/delta subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. Various versions of each of these subunits exist, either expressed from similar genes or the result of alternative splicing. Research on a highly similar protein in rabbit suggests the protein described in this record is cleaved into alpha-2 and delta subunits. Alternate transcriptional splice variants of this gene have been observed but have not been thoroughly characterized. [provided by RefSeq, Jul 2008]
CACNA2D4 Gene-Disease associations (from GenCC):
  • inherited retinal dystrophy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • retinal cone dystrophy 4
    Inheritance: AR, Unknown Classification: STRONG, MODERATE, LIMITED Submitted by: Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), G2P
  • cone-rod dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=1.9109855E-6).
BP6
Variant 12-1886237-T-C is Benign according to our data. Variant chr12-1886237-T-C is described in ClinVar as Benign. ClinVar VariationId is 262820.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.976 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA2D4NM_172364.5 linkc.979A>G p.Ile327Val missense_variant Exon 8 of 38 ENST00000382722.10 NP_758952.4 Q7Z3S7-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA2D4ENST00000382722.10 linkc.979A>G p.Ile327Val missense_variant Exon 8 of 38 1 NM_172364.5 ENSP00000372169.4 Q7Z3S7-1
CACNA2D4ENST00000586184.5 linkc.979A>G p.Ile327Val missense_variant Exon 8 of 37 5 ENSP00000465060.1 Q7Z3S7-5
CACNA2D4ENST00000587995.5 linkc.979A>G p.Ile327Val missense_variant Exon 8 of 37 5 ENSP00000465372.1 K7EJY1
CACNA2D4ENST00000585708.5 linkc.787A>G p.Ile263Val missense_variant Exon 8 of 37 5 ENSP00000467697.1 Q7Z3S7-6
CACNA2D4ENST00000588077.5 linkc.787A>G p.Ile263Val missense_variant Exon 8 of 38 5 ENSP00000468530.1 Q7Z3S7-4
CACNA2D4ENST00000444595.6 linkn.979A>G non_coding_transcript_exon_variant Exon 8 of 37 1 ENSP00000403371.2 E7EUE0

Frequencies

GnomAD3 genomes
AF:
0.916
AC:
139265
AN:
152006
Hom.:
63975
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.978
Gnomad AMI
AF:
0.834
Gnomad AMR
AF:
0.892
Gnomad ASJ
AF:
0.857
Gnomad EAS
AF:
0.999
Gnomad SAS
AF:
0.910
Gnomad FIN
AF:
0.894
Gnomad MID
AF:
0.844
Gnomad NFE
AF:
0.887
Gnomad OTH
AF:
0.889
GnomAD2 exomes
AF:
0.903
AC:
225118
AN:
249246
AF XY:
0.901
show subpopulations
Gnomad AFR exome
AF:
0.982
Gnomad AMR exome
AF:
0.890
Gnomad ASJ exome
AF:
0.845
Gnomad EAS exome
AF:
0.999
Gnomad FIN exome
AF:
0.891
Gnomad NFE exome
AF:
0.888
Gnomad OTH exome
AF:
0.881
GnomAD4 exome
AF:
0.894
AC:
1305653
AN:
1460190
Hom.:
584254
Cov.:
48
AF XY:
0.894
AC XY:
649146
AN XY:
726462
show subpopulations
African (AFR)
AF:
0.984
AC:
32922
AN:
33458
American (AMR)
AF:
0.892
AC:
39885
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.850
AC:
22210
AN:
26124
East Asian (EAS)
AF:
0.999
AC:
39664
AN:
39686
South Asian (SAS)
AF:
0.907
AC:
78251
AN:
86240
European-Finnish (FIN)
AF:
0.886
AC:
47291
AN:
53398
Middle Eastern (MID)
AF:
0.870
AC:
5016
AN:
5764
European-Non Finnish (NFE)
AF:
0.888
AC:
986155
AN:
1110486
Other (OTH)
AF:
0.900
AC:
54259
AN:
60312
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
7181
14363
21544
28726
35907
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
21376
42752
64128
85504
106880
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.916
AC:
139390
AN:
152124
Hom.:
64041
Cov.:
30
AF XY:
0.916
AC XY:
68131
AN XY:
74368
show subpopulations
African (AFR)
AF:
0.978
AC:
40594
AN:
41504
American (AMR)
AF:
0.892
AC:
13642
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.857
AC:
2973
AN:
3470
East Asian (EAS)
AF:
0.999
AC:
5165
AN:
5170
South Asian (SAS)
AF:
0.911
AC:
4377
AN:
4806
European-Finnish (FIN)
AF:
0.894
AC:
9447
AN:
10572
Middle Eastern (MID)
AF:
0.849
AC:
248
AN:
292
European-Non Finnish (NFE)
AF:
0.887
AC:
60306
AN:
67992
Other (OTH)
AF:
0.891
AC:
1881
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
607
1214
1821
2428
3035
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
904
1808
2712
3616
4520
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.894
Hom.:
230211
Bravo
AF:
0.919
TwinsUK
AF:
0.894
AC:
3316
ALSPAC
AF:
0.887
AC:
3417
ESP6500AA
AF:
0.977
AC:
4072
ESP6500EA
AF:
0.886
AC:
7459
ExAC
AF:
0.906
AC:
109585
Asia WGS
AF:
0.961
AC:
3344
AN:
3478
EpiCase
AF:
0.876
EpiControl
AF:
0.874

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Retinal cone dystrophy 4 Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cone dystrophy 3 Benign:1
May 28, 2019
Mendelics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.051
BayesDel_addAF
Benign
-0.73
T
BayesDel_noAF
Benign
-0.73
CADD
Benign
9.5
DANN
Benign
0.49
DEOGEN2
Benign
0.052
T;.;.;.;.
Eigen
Benign
-0.82
Eigen_PC
Benign
-0.50
FATHMM_MKL
Benign
0.23
N
MetaRNN
Benign
0.0000019
T;T;T;T;T
MetaSVM
Benign
-0.96
T
MutationAssessor
Benign
-2.0
N;.;.;N;.
PhyloP100
3.2
PrimateAI
Uncertain
0.61
T
PROVEAN
Benign
0.44
N;.;.;.;.
REVEL
Benign
0.11
Sift
Benign
1.0
T;.;.;.;.
Sift4G
Benign
1.0
T;T;T;T;T
Polyphen
0.0
B;.;.;.;.
Vest4
0.054
MPC
0.11
ClinPred
0.0026
T
GERP RS
5.2
Varity_R
0.092
gMVP
0.26
Mutation Taster
=83/17
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10735005; hg19: chr12-1995403; COSMIC: COSV54956232; COSMIC: COSV54956232; API